Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

 
Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria
JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)
 
ID 4507665
Author(s) Valent, P.; Akin, C.; Escribano, L.; Födinger, M.; Hartmann, K.; Brockow, K.; Castells, M.; Sperr, W. R.; Kluin-Nelemans, H. C.; Hamdy, N. A. T.; Lortholary, O.; Robyn, J.; van Doormaal, J.; Sotlar, K.; Hauswirth, A. W.; Arock, M.; Hermine, O.; Hellmann, A.; Triggiani, M.; Niedoszytko, M.; Schwartz, L. B.; Orfao, A.; Horny, H.-P.; Metcalfe, D. D.
Author(s) at UniBasel Hartmann, Karin
Year 2007
Title Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria
Journal European Journal of Clinical Investigation
Volume 37
Number 6
Pages / Article-Number 435-53
Mesh terms Clinical Trials as Topic, methods, standards; Diagnosis, Differential; Humans; Mastocytosis, diagnosis, therapy; Patient Selection
Abstract Although a classification for mastocytosis and diagnostic criteria are available, there remains a need to define standards for the application of diagnostic tests, clinical evaluations, and treatment responses. To address these demands, leading experts discussed current issues and standards in mastocytosis in a Working Conference. The present article provides the resulting outcome with consensus statements, which focus on the appropriate application of clinical and laboratory tests, patient selection for interventional therapy, and the selection of appropriate drugs. In addition, treatment response criteria for the various clinical conditions, disease-specific symptoms, and specific pathologies are provided. Resulting recommendations and algorithms should greatly facilitate the management of patients with mastocytosis in clinical practice, selection of patients for therapies, and the conduct of clinical trials.
Publisher Wiley
ISSN/ISBN 0014-2972 ; 1365-2362
edoc-URL https://edoc.unibas.ch/70833/
Full Text on edoc No
Digital Object Identifier DOI 10.1111/j.1365-2362.2007.01807.x
PubMed ID http://www.ncbi.nlm.nih.gov/pubmed/17537151
Document type (ISI) Journal Article, Review
 
   

MCSS v5.8 PRO. 0.345 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
14/05/2024